Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 117,942 | 118,864 | 118,404 | 75,239 | 68,259 |
| Cost of Goods | 9,104 | 4,886 | 4,667 | 5,304 | 4,085 |
| Gross Profit | 108,838 | 113,978 | 113,737 | 69,935 | 64,174 |
| Operating Expenses | 207,090 | 211,237 | 169,535 | 257,512 | 157,250 |
| Operating Income | -98,148 | -96,373 | -55,131 | -187,273 | -92,991 |
| Interest Expense | 19,159 | 24,292 | 21,039 | 5,379 | 5,642 |
| Other Income | -10,884 | 58,945 | 28,766 | 11,309 | -13,832 |
| Pre-tax Income | -128,191 | -61,720 | -47,404 | -181,343 | -112,465 |
| Income Tax | 451 | 12,634 | 22,288 | 84 | 222 |
| Net Income Continuous | -128,642 | -74,354 | -69,692 | -181,427 | -112,687 |
| Net Income | $-128,642 | $-74,354 | $-69,692 | $-181,427 | $-112,687 |
| EPS Basic Total Ops | -1.83 | -1.02 | -1.03 | -2.78 | -1.81 |
| EPS Basic Continuous Ops | -1.83 | -1.01 | -1.03 | -2.78 | -1.81 |
| EPS Diluted Total Ops | -1.83 | -1.02 | -1.03 | -2.78 | -1.81 |
| EPS Diluted Continuous Ops | -1.83 | -1.01 | -1.03 | -2.78 | -1.81 |
| EBITDA(a) | $-82,750 | $-82,749 | $-42,986 | $-135,899 | $-83,833 |